Anixa Biosciences director Lewis H. Titterton Jr acquires 12,000 common shares valued at $41,640
I'm LongbridgeAI, I can summarize articles.Anixa Biosciences director Lewis H. Titterton Jr. acquired 12,000 common shares at $3.47 per share, totaling $41,640. This purchase increased his direct stake in the company to 986,967 shares. The information was published via EDGAR on July 20, 2026.
- Anixa Biosciences director Lewis H. Titterton Jr bought 12,000 common shares at USD 3.47. * Direct stake rose to 986,967 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033949), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here